Home > API & Intermediate > Immune System Medication > Tofacitinib Citrate Manufacturers > Tofacitinib Citrate

Tofacitinib Citrate

CAS NO.： 540737-29-9

FOB Price： NEGOTIABLE Get Latest Price

Specification： 99%

Documentation： Get COA after inquiry

Lead Time： In Stock

Max Capacity： -

Pallets Packing	20'FCL		40'FCL
Pallets Packing	With	Without	With	Without
25KG/Fibre Drum	--	20 MT	--	--

Product Detail

Properties

Tofacitinib Citrate

Chinese name：枸橼酸托法替布

CAS NO：540737-29-9

Molecular formula：C22H28N6O8

Molecular weight：504.49

Specification：In-house

Common dosage forms：Tablets / sustained release tablets

Product status:I

Structural formula：

Application:Treatment of rheumatoid arthritis

Properties

Tofatinib citrate combined with methotrexate in the treatment of active rheumatoid arthritis with insufficient response to tumor necrosis factor inhibitors.

CAS No.

540737-29-9

Formula

C22H28N6O8

Molecular Mass

504.49300

Exact Mass

504.19700

PSA

221.04000

Logp

0.23418

IUPAC

2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile

Matter Classification

organic

Category

Melting Point

201 °C (decomp)

Appearance

white powder

HS Code

29335990

UN No.

0.0

DG-Class

0.0

Send your message to this supplier

To：

Sichuan Renan Pharmaceutical Co.,Ltd.

Not exactly what you want? One request, multiple quotations Get Quotations Now >>

Supplier's main products

Sichuan Renan Pharmaceutical Co.,Ltd.

11YRS

Business Type：

Manufacturing

Country/Region：

Sichuan, China

Contacts：

Manager Zhang

Position Title：

Export Director

Tel：

0086-826-8888969-8199

Email：

renan@chemmail.net

Visit Factory

Get Free Samples

Less than 1KG required

b

Send Email

Tofacitinib Citrate

Chinese name：枸橼酸托法替布

CAS NO：540737-29-9

Molecular formula：C22H28N6O8

Molecular weight：504.49

Specification：In-house

Common dosage forms：Tablets / sustained release tablets

Product status:I

Structural formula：

Application:Treatment of rheumatoid arthritis